Total mesorectal excision - The new golden standard of surgery for rectal cancer

Annals of Medicine

Volumn 29, Issue 2, 1997, Pages 127-133

  Enker, Warren E ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Adjuvant radiation and chemotherapy; Complete circumferential mesorectal excision; Local recurrence; Rectal cancer; Sexual and urinary function; Sphincter preservation; Total mesorectal excision

Indexed keywords

ANTINEOPLASTIC AGENT;

ANUS SPHINCTER; ARTICLE; BLADDER DYSFUNCTION; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COLOSTOMY; HUMAN; IMPOTENCE; MESENTERY LYMPH NODE; PATIENT CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RECTUM CANCER; RECTUM SURGERY; SURGICAL TECHNIQUE;

EID: 0030914380     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899709113698     Document Type: Article

References (27)

1. Enker WE, Latter UT, Block GE. Enhanced survival of patients with colon and rectal cancer is based upon wide anatomic resection. Ann Surg 1979; 190: 350-60.
2. Heald RJ. A new approach to rectal cancer. Br J Hosp Med 1979; 22: 277-81.
3. Enker WE, Thaler HT, Cranor ML, Polyak T. Total mesorectal excision in the operative treatment of rectal cancer. J Am Coll Surg 1995; 181: 335-46.
4. Enker WE. Sphincter-preserving operations for rectal cancer. Oncology 1996; 10: 1673-89.
5. Church JM, Raudkivi PJ, Hill GL. The surgical anatomy of the rectum - a review with particular relevance to the hazards of rectal mobilization. Int J Colorect Dis 1987; 2: 158-66.
6. Quirke P, Durdey P, Dixon MF, et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986; 1: 996-9.
7. Adam IJ, McHamdee MO, Martin IG, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994; 344: 707-11.
8. Ng IOL, Luk IS, Yuen ST. Surgical lateral clearance margins in resected rectal carcinomas: a multivariate analysis of clinicopathologic features. Cancer 1993; 71: 1972-6.
9. Reynolds JV, Joyce WP, Dolan J, Sheahan K, Hyland JM. Pathological evidence in support of total mesorectal excision in the management of rectal cancer. Br J Surg 1996; 83: 1112-5.
10. Havenga K, Enker WE, McDermott K, Cohen AM, Minsky BD, Guillem J. Male and female sexual and urinary function after total mesorectal excision with autonomic nerve preservation for carcinoma of the rectum. J Am Coll Surg 1996; 182: 495-502.
11. MacFarlane J, Ryall RDH, Heald RJ. Mesorectal excision for rectal cancer. Lancer 1993; 341: 457-60.
12. Enker WE. Potency, cure, and local control in the operative treatment of rectal cancer. Arch Surg 1992; 127: 1396-402.
13. Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991; 324: 709-15.
14. Gastro-intestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 1985; 312: 1465-72.
15. Paty PB, Enker WE, Cohen AM, Lauwers GY. Treatment of rectal cancer by low anterior resection with coloanal anastomosis. Ann Surg 1994; 219: 365-73.
16. Enker WE. Total mesorectal excision with sphincter and autonomic-nerve preservation in the treatment of rectal cancer. Curr Tech Gen Surg 1996; 5: 1-8.
17. Havenga K, DeRuiter MC, Enker WE, Welvaart K. Anatomical basis of autonomic nerve-preserving total mesorectal excision for rectal cancer. Br J Surg 1996; 83: 384-8.
18. Heart RW, Steele GD, Menck HR, Chmiel JS, Ocwieja KE, Winchester DP. Management and survival of patients with adenocarcinoma of the colon and rectum: a national survey of the Commission on Cancer. J Am Coll Surg 1995; 181: 225-36.
19. Tartter PI. The association of blood transfusion with colorectal cancer recurrence. Ann Surg 1992; 216: 633-8.
20. Sugihara K, Moriya Y, Akasu T, Fujita S. Pelvic autonomic nerve preservation for rectal cancer: oncological and functional outcome. Cancer 1996; 78: 1871-80.
21. Minsky BD. Preoperative combined modality treatment for rectal cancer. Oncology 1994; 8: 53-8.
22. Swedish Rectal Cancer Trial. Local recurrence rates in a randomized multicentre trial of preoperative radiotherapy compared with operation alone in resectable rectal carcinoma. Eur J Surg 1996; 162: 397-402.
23. Stockholm Colorectal Cancer Study Group. Randomized study on preoperative radiotherapy in rectal carcinoma. Ann Surg Oncol 1996; 3: 423-30.
24. Wolmark N, Fisher B. An analysis of survival and treatment failure following abdominoperineal resection and sphincter preserving resection in Dukes' B and C rectal carcinoma. A report of the NSABP clinical trials. Ann Surg 1986; 204: 480-7.
25. Dutch Colorectal Cancer Group. Total Mesorectal Excision (TME) with or without Pre-operative Radiotherapy in the Treatment of Primary Rectal Cancer. A multicenter phase III study. The Netherlands: The University of Leiden, 1996.
26. Norstein J, Bergan A, Langmark F. Risk factors for local recurrence after radical surgery for rectal carcinoma: a prospective multicentre study. Br J Surg 1993; 80 (Suppl): 22.
27. Quirke P. The pathologist's role in the evaluation of local recurrence in rectal cancer. Surgical Workshop and Prosection Course, Royal College of Surgeons of London, London, UK, 25 April, 1995.